Statement of Organization, Functions and Delegations of Authority, 3610 [2015-01131]

Download as PDF 3610 Federal Register / Vol. 80, No. 15 / Friday, January 23, 2015 / Notices Dated: January 15, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–01114 Filed 1–22–15; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Statement of Organization, Functions and Delegations of Authority This notice amends Part R of the Statement of Organization, Functions and Delegations of Authority of the Department of Health and Human Services (HHS), Health Resources and Services Administration (HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 79 FR 75164–75165 dated December 17, 2014). This notice reflects organizational changes in the Health Resources and Services Administration (HRSA), Healthcare Systems Bureau (HSB). Specifically, this notice: (1) Updates the functional statement for the Division of National Hansen’s Disease Programs (RRH). Chapter RR—Healthcare Systems Bureau tkelley on DSK3SPTVN1PROD with NOTICES Section RR–20, Functions Delete the functional statement for the Division of National Hansen’s Disease Programs (RRH) in its entirety and replace with the following: Division of National Hansen’s Disease Programs (RRH) The National Hansen’s Disease Programs (NHDP) in accordance with regulations of the Public Health Service (PHS) Act, Sec. 320 as amended by Sec. 211, PL105–78); (1) provides care and treatment for persons with Hansen’s Disease (leprosy), including managing a national short-term and outpatient health care delivery program providing specialized services to persons with Hansen’s Disease; (2) conducts and promotes the coordination of research (including clinical research), investigations, demonstrations, and studies relating to the causes, diagnosis, treatment, control, and prevention of Hansen’s disease and other 18:05 Jan 22, 2015 Jkt 235001 Section RR–30, Delegations of Authority All delegations of authority and redelegations of authority made to HRSA officials that were in effect immediately prior to this reorganization, and that are consistent with this reorganization, shall continue in effect pending further re-delegation. This reorganization is effective upon date of signature. Dated: January 16, 2015. Mary K. Wakefield, Administrator. [FR Doc. 2015–01131 Filed 1–22–15; 8:45 am] Section RR—00, Mission The Healthcare Systems Bureau (HSB) protects the public health and improves the health of individuals through an array of programs that provide national leadership and direction in targeted areas. VerDate Sep<11>2014 mycobacterial diseases and complications related to such diseases; (3) conducts training in the diagnosis and management of Hansen’s disease and related complications; (4) provides education and training to staff from the outpatient Hansen’s Disease Clinics and private physicians; (5) operates and oversees the National Hansen’s Disease Museum and Cemetery; (6) consults on the coordination of activities within HRSA and HHS, and with other federal agencies, state and local governments, and other public and private organizations involved in Hansen’s Disease activities; and (7) manages a network of outpatient clinics through contracts providing care to persons with Hansen’s Disease. BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Application (P01). Date: February 19, 2015. Time: 11:00 a.m. to 2:00 p.m. PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health, NIAID, 5601 Fishers Lane, Rockville, MD 20892, 240–669– 5881, ec17w@nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: February 23, 2015. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Room 3F100, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Quirijn Vos, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, DHHS/NIH/NIAID, 5601 Fishers Lane, Rockville, MD 20892, 240–669–5059, qvos@ niaid.nih.gov. Name of Committee: National Institute of Allergy and Infectious Diseases Special Emphasis Panel; NIAID Investigator Initiated Program Project Applications (P01). Date: February 26, 2015. Time: 11:00 a.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5601 Fishers Lane, Rockville, MD 20892 (Telephone Conference Call). Contact Person: Eleazar Cohen, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health, NIAID, 5601 Fishers Lane, Rockville, MD 20892, 240–669– 5881, ec17w@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 16, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–01087 Filed 1–22–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the E:\FR\FM\23JAN1.SGM 23JAN1

Agencies

[Federal Register Volume 80, Number 15 (Friday, January 23, 2015)]
[Notices]
[Page 3610]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-01131]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Statement of Organization, Functions and Delegations of Authority

    This notice amends Part R of the Statement of Organization, 
Functions and Delegations of Authority of the Department of Health and 
Human Services (HHS), Health Resources and Services Administration 
(HRSA) (60 FR 56605, as amended November 6, 1995; as last amended at 79 
FR 75164-75165 dated December 17, 2014).
    This notice reflects organizational changes in the Health Resources 
and Services Administration (HRSA), Healthcare Systems Bureau (HSB). 
Specifically, this notice: (1) Updates the functional statement for the 
Division of National Hansen's Disease Programs (RRH).

Chapter RR--Healthcare Systems Bureau

Section RR--00, Mission

    The Healthcare Systems Bureau (HSB) protects the public health and 
improves the health of individuals through an array of programs that 
provide national leadership and direction in targeted areas.

Section RR-20, Functions

    Delete the functional statement for the Division of National 
Hansen's Disease Programs (RRH) in its entirety and replace with the 
following:
Division of National Hansen's Disease Programs (RRH)
    The National Hansen's Disease Programs (NHDP) in accordance with 
regulations of the Public Health Service (PHS) Act, Sec. 320 as amended 
by Sec. 211, PL105-78); (1) provides care and treatment for persons 
with Hansen's Disease (leprosy), including managing a national short-
term and outpatient health care delivery program providing specialized 
services to persons with Hansen's Disease; (2) conducts and promotes 
the coordination of research (including clinical research), 
investigations, demonstrations, and studies relating to the causes, 
diagnosis, treatment, control, and prevention of Hansen's disease and 
other mycobacterial diseases and complications related to such 
diseases; (3) conducts training in the diagnosis and management of 
Hansen's disease and related complications; (4) provides education and 
training to staff from the outpatient Hansen's Disease Clinics and 
private physicians; (5) operates and oversees the National Hansen's 
Disease Museum and Cemetery; (6) consults on the coordination of 
activities within HRSA and HHS, and with other federal agencies, state 
and local governments, and other public and private organizations 
involved in Hansen's Disease activities; and (7) manages a network of 
outpatient clinics through contracts providing care to persons with 
Hansen's Disease.

Section RR-30, Delegations of Authority

    All delegations of authority and re-delegations of authority made 
to HRSA officials that were in effect immediately prior to this 
reorganization, and that are consistent with this reorganization, shall 
continue in effect pending further re-delegation.
    This reorganization is effective upon date of signature.

    Dated: January 16, 2015.
Mary K. Wakefield,
Administrator.
[FR Doc. 2015-01131 Filed 1-22-15; 8:45 am]
BILLING CODE 4165-15-P